使用含有聚乙烯糖醇的化剂控制放射性免疫结合物的药理动力学
Kazuma Nakashima1, Hiroki Jinda1, Hiroki Shimohara1
1Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.
概括
研究人员使用PEGylated合剂开发了新的放射性免疫结合物 (RIC),以改善癌症治疗中的瘤向. 马尔-DOTA-PEG48 RIC在体内显示出优异的瘤积累和有利的瘤/血液比率.
科学领域:
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
- 生物结合的生物结合
背景情况:
- 放射性免疫结合剂 (RICs) 结合了单克隆抗体 (mAbs) 和放射性同位素 (RIs) 用于癌症治疗.
- 有限的瘤对血液比率历来限制了RIC的疗效.
- 需要新的策略来增强RIC瘤向和保留.
研究的目的:
- 开发基于DOTA的新型合剂,具有离散的聚乙烯糖醇 (dPEG) 支架.
- 合成和评估具有改善瘤积累和瘤/血液比率的RIC.
- 调查PEGylation对RIC药理动力学和细胞保留的影响.
主要方法:
- 合成Mal-DOTA-PEG24,Mal-DOTA-PEG48,以及Mal-DOTA-(PEG48) 3类结合剂的合成.
- 使用这些新化剂开发基于Trastuzumab的RIC.
- 在RIC放射性分布在HER2/neu-表达SK-OV-3细胞上的体外评估.
- 在体内评估瘤积累和相关模型中的瘤/血液比率.
主要成果:
- 使用PEGylated合剂的RIC显示了不同的放射性分布.
- 较高的分子量PEGylation增加了细胞内放射代谢物保留,但也增加了细胞表面解离.
- 马尔-DOTA-PEG48 RIC在体内呈现出最高的瘤积累和有利的瘤/血液比率.
- 化剂的优化PEGylation显著影响了RIC的药理动力学.
结论:
- 马尔-DOTA-PEG48作为一个有前途的放射合成平台,用于开发RIC.
- 优化PEGylation对于控制RIC药理动力学和增强治疗潜力至关重要.
- 这些新型RIC显示了瘤向和瘤保留的改进,用于瘤学应用.
相关概念视频
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
01:26Enhanced Elimination of Poison
862
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
862
01:14Phase II Conjugation Reactions: Overview
763
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
763
01:19Complexation Equilibria: The Chelate Effect
1.2K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.2K